2022
DOI: 10.3389/fphar.2022.804189
|View full text |Cite
|
Sign up to set email alerts
|

Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor

Abstract: Of the patients infected with coronavirus disease 2019 (COVID-19), approximately 14–53% developed liver injury resulting in poor outcomes. Drug-induced liver injury (DILI) is the primary cause of liver injury in COVID-19 patients. In this study, we elucidated liver injury mechanism induced by drugs of pharmacologic treatments against SARS-CoV-2 (DPTS) using bioinformatics and systems biology. Totally, 1209 genes directly related to 216 DPTS (DPTSGs) were genes encoding pharmacokinetics and therapeutic targets … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 88 publications
(105 reference statements)
0
1
1
Order By: Relevance
“…Lastly, drug-elicited liver injury may also account for laboratory test abnormalities. 3,24 However, there was no significant difference in drug use among the liver injury group, abnormal group and normal group in this study, except for a vasoactive drug. However, the vasoactive drug was not an independent risk factor for the occurrence of liver injury in the logistic analysis.…”
contrasting
confidence: 56%
“…Lastly, drug-elicited liver injury may also account for laboratory test abnormalities. 3,24 However, there was no significant difference in drug use among the liver injury group, abnormal group and normal group in this study, except for a vasoactive drug. However, the vasoactive drug was not an independent risk factor for the occurrence of liver injury in the logistic analysis.…”
contrasting
confidence: 56%
“…Importantly, NRF2 activation has been shown to benefit respiratory infections in various animal models (Muchtaridi et al, 2022). NRF2 exerts anti-inflammatory effects by inhibiting pro-inflammatory genes such as IL6 and IL1B (Huang et al, 2022). NRF2 induces the expression of genes that promote specificity of macrophages such as the macrophage receptor, which is responsible for bacterial phagocytosis (Schaefer et al, 2022), and the cluster of differentiation gene 36 (CD36), which resists viral infection (Hillier et al, 2022).…”
Section: Top Features Identified Via Multiple Methodsmentioning
confidence: 99%